China Antibody-B (03681.HK) plans to issue a total of approximately 112.8 million subscription shares with a net fundraising amount of about 1.24 billion Hong Kong dollars.

The financial news app of Wisdom Finance reports that China Antibody-B (03681.HK) has announced that on May 13, 2025, the company entered into 26 subscription agreements with 26 subscribers (all independent third parties). The company will issue a total of approximately 112.8 million subscription shares to the subscribers at a subscription price of HK$1.10 per share.